Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Peter Thiel-Backed Fellows' Startup Mercor Targets $10 Billion Valuation As OpenAI, Meta, Tesla Turn To Its AI Training Experts: Report

Mercor, founded by three Thiel Fellows who dropped out of Harvard, is reportedly pursuing a Series C funding round targeting a $10 billion valuation amid surging demand from artificial intelligence companies for specialized training experts.

Benzinga

Broadcom Ties CEO Fortune To Explosive AI Revenue Targets

Broadcom Inc. (NASDAQ:AVGO) has granted Chief Executive Officer Hock E. Tan a long-term equity award that directly links his compensation to the company’s success in artificial intelligence, underscoring the board’s commitment to retaining his leadership through the end of the decade.

Benzinga

Google Cloud Expects Over 50% Of Its $106 Billion Backlog To Convert To Revenue In The Next Two Years

Alphabet Inc.‘s (NASDAQ:GOOGL) (NASDAQ:GOOG) Google Cloud has projected a revenue increase of at least $58 billion in the next two years, underlining the division’s pivotal role in the company’s future.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Elon Musk Says The Government Is 'Unfixable,' Hails Trump's Crypto Czar David Sacks: 'Haven't Been To DC Since May'

Billionaire and Tesla Inc. (NASDAQ:TSLA) CEO Elon Musk has said that he hasn't been to Washington, D.C. since May, calling his time with the Trump administration a "side quest."

Benzinga

Microsoft Scraps Pandemic-Era Flexibility, Orders Workers Back To Office 3 Days A Week In 2026 As AI Push Demands More Collaboration

Microsoft Corp. (NASDAQ:MSFT) is tightening its hybrid work model, ending years of broad remote flexibility and requiring employees to return to the office at least three days a week beginning in 2026.

Benzinga

Volatile Trading For EPSM: Shares Rocket 411% Then Plunge 58% Following SEC Filing

Epsium Enterprise Ltd. (NASDAQ:EPSM) opened pre-market trading with significant volatility following Tuesday’s extraordinary 411.49% surge that lifted shares from $26.98 to $138. According to Benzinga Pro data, in the early trading session, the Chinese company retreated to $58.01, down 57.96%, indicating extreme price instability.

Benzinga

Vivek Ramaswamy-Backed Strive, Asset Entities Get Shareholder Approval To Merge, Launch $1.5 Billion Public Bitcoin Treasury Company

Asset Entities Inc. (NASDAQ:ASST) shareholders approved a reverse merger with Vivek Ramaswamy-backed Strive Enterprises, creating what executives call a leading public Bitcoin (CRYPTO: BTC) treasury company with potential $1.5 billion in funding.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Palantir CEO Alex Karp Denies Spying On Americans, Says Firm Has 'Worst' Tech To Abuse Civil Liberties

On Tuesday, Palantir Technologies Inc. (NASDAQ:PLTR) CEO Alex Karp strongly pushed back against claims the company spies on U.S. citizens, defending its platforms as among the hardest technologies in the world to abuse as its stock price and revenue surge.

Benzinga

Is Paychex Stock Underperforming the Nasdaq?

Paychex has notably underperformed the Nasdaq Composite over the past 52 weeks, and analysts remain cautious about the stock’s prospects.

Barchart

Asset Entities Stock Trends, Soars 52%, On Strive Merger Approval: Another Bitcoin Treasury Company In The Making

Asset Entities Inc. (NASDAQ:ASST) is trending on Wednesday.

Benzinga

Mark Zuckerberg's Costly AI Talent Hunt Sparks Backlash As Million-Dollar Recruits Quit, Secretive 'TBD Lab' Breeds Tension At Meta: Report

Meta Platforms Inc. (NASDAQ:META) faces mounting internal tensions after CEO Mark Zuckerberg‘s artificial intelligence recruitment drive sparked employee departures and compensation disputes.

Benzinga

Elon Musk Shares Updates On Robots, Starlink-Enabled Smartphones, AI Push In Latest Interview, Says Optimus Could Be 'Biggest Product Ever'

Tesla Inc. (NASDAQ:TSLA) CEO Elon Musk has shared updates on autonomous driving, Optimus humanoid robots and artificial intelligence pursuits during a recent event.

Benzinga

Jim Cramer Says Microsoft Paying Amazon's Anthropic For AI Is 'Big': Redmond Shifting Strategy?

On Tuesday, Jim Cramer said Microsoft Corporation's (NASDAQ:MSFT) decision to pay Amazon.com, Inc. (NASDAQ:AMZN) -backed Anthropic for artificial intelligence features in Office apps marks a major change in strategy after years of relying heavily on OpenAI.

Benzinga

Thinnest iPhone Ever, Longest Battery: Enough To Spark A Supercycle For Apple? — Daniel Newman Has Doubts

On Tuesday, Apple Inc.'s (NASDAQ:AAPL) "Awe Dropping" event drew a mix of enthusiasm and skepticism from analysts, who praised the company's camera upgrades and thinner designs but questioned whether the iPhone 17 lineup offers enough innovation to ignite investor excitement.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

OpenAI CEO Sam Altman Calls iPhone Air 'First Upgrade I Really Wanted In Awhile' Following Apple's Latest Launch

OpenAI CEO Sam Altman praised Apple Inc. (NASDAQ:AAPL) for its iPhone 17 launch on Tuesday, marking the first Apple upgrade he’s genuinely wanted in years. His endorsement comes as Apple shares fell 1.83% following the “Awe Dropping” event unveiling the company’s latest device lineup.

MarketBeat

Is Qualcomm Tesla’s Next Rival in Autonomous Driving?

Tesla may still dominate the autonomous headlines, but Qualcomm’s partnership with BMW make it an interesting alternative for investors to consider.

The Independent UK

Eric Trump will no longer serve as board director of cryptocurrency firm

IN FULL

Benzinga

What Happened With Bitcoin Treasury Kindly MD Stock Today?

Kindly MD, Inc. (NASDAQ:NAKA) shares ran on Tuesday on likely sympathy with fellow crypto-treasury company QMMM Holdings Ltd (NASDAQ:QMMM), which soared more than 1700%.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Eric Trump booted from cryptocurrency board after company talks with stock regulators

Fintech firm Alt5 Sigma announced in August that President Donald Trump’s son Eric was joining its board of directors

Benzinga

Synopsys Stock Drops After Disappointing Q3 Earnings

Synopsys, Inc. (NASDAQ:SNPS) released its third-quarter results after Tuesday's closing bell. Here's a look at the key figures from the quarter.

Barchart

Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures...

Benzinga

Quantum Stock Tracker: Nvidia Backs Quantinuum; D-Wave, IonQ Announce New Execs

Quantum stocks climbed Tuesday as anticipated interest rate cuts and a broader bullish move in tech stocks provided a supportive backdrop for innovation sectors like quantum computing.

Benzinga

Oracle Turns 50 Soon - And It's Burning Billions To Stay Relevant

For a company nearing its 50th birthday, Oracle Corp (NYSE:ORCL) is acting more like a cash-burning startup than a tech elder statesman. Once the software king of the '80s and '90s, Oracle stumbled through the cloud transition but is now betting big on AI infrastructure.

Benzinga

Regeneron's Libtayo Combo Achieves Nearly Double Survival Rate In Advanced Lung Cancer Compared To Chemotherapy

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Tuesday announced five-year follow-up results on overall survival (OS) from the Phase 3 EMPOWER-Lung 3 trial of Libtayo (cemiplimab) plus platinum-based chemotherapy versus chemotherapy alone as a first-line treatment for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with no EGFR, ALK,…

Benzinga

Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis

Amgen Inc. (NASDAQ:AMGN) and Kyowa Kirin released preliminary topline results from the ASCEND study evaluating rocatinlimab in adults and adolescents with moderate to severe atopic dermatitis (AD) on Tuesday.

1 … 115 116 117 118

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations